Cell-Based Ophthalmic Therapies Market Research: Growth Projections and Trends 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the cell-based ophthalmic therapies market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Cell-Based Ophthalmic Therapies Market from 2026 to 2030?

The cell-based ophthalmic therapies market size has experienced significant expansion in recent years. It is anticipated to increase from $1.48 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.9%. The growth witnessed during the historic period can be attributed to factors such as limited treatment options for degenerative eye diseases, the growing prevalence of retinal and corneal disorders, an increasing aging population, rising awareness of regenerative medicine, and the expansion of ophthalmic research infrastructure.

The cell-based ophthalmic therapies market is set for substantial growth in the coming years, with projections indicating it will reach **$3.78 billion in 2030**, advancing at a **compound annual growth rate (CAGR) of 20.5%**. This expansion during the forecast period is driven by progress in stem cell and gene editing technologies, increased financial input into regenerative ophthalmology, a rise in regulatory clearances for cell-based treatments, a growing need for enduring vision restoration solutions, and the proliferation of specialized ophthalmic treatment centers. Noteworthy trends during this time include a greater embrace of stem cell and gene therapies for vision recovery, a heightened emphasis on regenerative interventions for retinal and corneal conditions, an increase in clinical trials for **cell-based ophthalmic therapies**, the broadening scope of personalized and precision eye treatments, and superior long-term patient outcomes compared to conventional ophthalmic procedures.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27246&type=smp

What Drivers Are Affecting Demand In The Cell-Based Ophthalmic Therapies Market?

A growing incidence of ophthalmic disorders is anticipated to stimulate the expansion of the cell-based ophthalmic therapies market in the future. Ophthalmic disorders are defined as conditions or diseases impacting the eyes, leading to vision problems or damage to ocular health. These disorders are becoming more common as the aging population faces an elevated risk of age-related eye diseases, which can cause vision impairment, especially with extended life expectancy. Cell-based ophthalmic therapies function by repairing or replacing compromised retinal and eye cells to restore vision and prevent further harm, while also fostering regeneration and improving overall eye function. For instance, in August 2024, the Welsh Government, a UK-based government agency, reported that ophthalmology departments in Wales recorded over 35,000 admissions in 2023-24, representing a 5.8% increase from 2022-2023. Thus, the rising prevalence of ophthalmic disorders is propelling the growth of the cell-based ophthalmic therapies market.

Which Segments Are Gaining Traction In The Cell-Based Ophthalmic Therapies Market?

The cell-based ophthalmic therapies market covered in this report is segmented –

1) By Therapy Type: Stem Cell Therapy, Gene Therapy, Tissue Engineering

2) By Application: Retinal Disorders, Corneal Disorders, Glaucoma, Other Applications

3) By End-User: Hospitals, Ophthalmic Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Retinal Pigment Epithelium Cell Therapy, Limbal Stem Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector Based Gene Therapy, In-Vivo Gene Therapy, Ex-Vivo Gene Therapy, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy

3) By Tissue Engineering: Bioengineered Corneal Tissue, Amniotic Membrane Transplantation, Hydrogel-Based Scaffolds, Synthetic Polymer Scaffolds, Decellularized Tissue Constructs

Which Trends Are Influencing The Development Of The Cell-Based Ophthalmic Therapies Market?

Leading companies operating in the cell-based ophthalmic therapies market are concentrating on developing advanced treatments, such as allogeneic cell therapy, to address unfulfilled demands in managing corneal endothelial diseases. Allogeneic cell therapy refers to a treatment approach that employs stem cells or other cells donated by a genetically different individual of the same species to repair or replace damaged tissues or to treat various diseases. For instance, in September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, announced the commercial launch of Vyznova (neltependocel) in Japan. This product is specifically designed for the treatment of bullous keratopathy, a debilitating condition affecting the corneal endothelium. Vyznova is considered the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, having secured both regulatory and reimbursement approvals in Japan.

Who Are The Core Companies Influencing Trends In The Cell-Based Ophthalmic Therapies Market?

Major companies operating in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-based-ophthalmic-therapies-global-market-report

Which Regions Are Projected To Dominate The Cell-Based Ophthalmic Therapies Market In The Coming Years?

North America was the largest region in the cell-based ophthalmic therapies market in 2025. The regions covered in the cell-based ophthalmic therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell-Based Ophthalmic Therapies Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27246&type=smp

Browse Through More Reports Similar to the Global Cell-Based Ophthalmic Therapies Market 2026, By The Business Research Company

Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/breathable-membranes-global-market-report

Specialty Breathable Membranes Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-breathable-membranes-global-market-report

Vacuum Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795